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Monocyte-derived macrophages play a key role in pathogenesis of atherosclerosis. However, the mechanism ofactivating 
macrophages in atheromatous lesions has not been fully investigated. This report describes the contribution of phospha- 
tidylinositol turnover to the uptake of low density lipoproteins (LDL) by macrophages. Both native and acetyl LDL 
stimulated inositol 1,4,5-triphosphate (IP3)formation in a dose-dependent manner at concentrations of 0-70/~g/ml. The 
potency of IP 3 formation by acetyl LDL (0.44 nmol/mg protein) was 2-fold higher than that by native LDL (0.21 nmol/ 
mg protein). Time course studies howed that a maximal effect of IP 3 formation by acetyl LDL at concentrations of 
30 gg/ml was observed at 3 min. Longer incubation diminished IP 3 formation. Oxidized LDL also stimulated IP 3 forma- 
tion with a similar efficiency to acetyl LDL. It was indicated that chemically modified LDL which were taken up through 
the scavenger receptor pathway activated the macrophages by mediating the phosphatidylinositol hydrolysis and IP 3 
formation. 
LDL; Macrophage; Phosphatidylinositol turnover 
1. INTRODUCTION 
It has been well established that activated 
macrophages are essential in many pathological 
conditions, such as wound repair, inflammation 
and immune response [1]. Monocyte-derived 
macrophages are identified in atheromatous le- 
sions and considered to play a key role in 
pathogenesis of atherosclerosis [2]. As well as 
other pathological conditions, macrophages in 
atheromatous le ions might be activated. The pro- 
cess of lipid accumulation i macrophages has 
been well investigated and two receptor pathways 
of lipid accumulation are proposed. One is LDL 
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receptor, which binds to native LDL and is taken 
up into macrophages [3]. The other is scavenger 
receptor, which binds to chemically modified 
LDL, such as acetyl LDL, before internalization 
[4]. The properties of scavenger receptor are the 
large number of the receptors [5], high internaliza- 
tion index [5], and lack of control by cell 
cholesterol content [6,7]. The characterization f 
LDL receptor and scavenger receptor made the 
mechanism of lipid uptake by macrophages clear, 
however, the mechanism of activating the 
macrophages remains to be clarified. 
IP3 is well known as a second messenger pro- 
duced by a receptor-mediated inositol phospho- 
lipid hydrolysis and plays a central role in intra- 
cellular signal transduction by releasing calcium 
from the endoplasmic reticulum store [8,9]. This 
communication describes the contribution of 
phosphatidylinositol turnover to native and chemi~ 
cally modified LDL uptake by human monocyte- 
derived macrophages. 
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2. MATERIALS  AND METHODS 
2.1. Macrophage preparation 
Human monocyte-derived macrophages were separated as 
described by Boyum [10]. Briefly, heparinized venous blood 
from a normolipemic healthy volunteer was obtained after 
overnight fasting. The lymphocyte fraction was separated by 
FicoU-Paque (Pharmacia) density-gradient centrifugation from 
the blood. The mononuclear cell layer was washed three times 
with calcium-free phosphate-buffered saline (PBS) to remove 
platelets. The platelet-free mononuclear cells were suspended in
RPMI 1640 containing sterile 10070 autologous serum, 
100 U/ml penicillin, and 100,ug/ml streptomycin at the final 
cell concentration of 107/ml approx., seeded on 35 mm culture 
dishes and incubated at 37°C for 2 h. The non-adherent cells 
were removed by rinsing the dish with RPMI 1640. The 
adherent cells were cultured for 5 days at 37°C in CO2 in- 
cubator, changing the medium every 2 days. On the 5th day of 
culture, the medium was changed to serum-free RPMI 1640 and 
incubated for 2 days. 
2.2. LDL preparation 
Native LDL (d = 1.020-1.060 g/ml) was isolated by sequen- 
tial ultracentrifugation by the method of Havel et al. [11], Pro- 
tein was determined as described by Bradford [12], utilizing 
bovine serum albumin as the standard. Acetyl LDL was 
prepared as described by Basu et al. [13]. Copper-oxidized LDL 
was prepared by incubating native LDL with 5/~M CuSO4 in 
calcium-free PBS at 37°C for 24 h [14]. 
2,3. IP3 assay 
A human monocyte-derived macrophage culture, which was 
incubated in RPMI 1640 containing 10070 autologous serum for 
5 days and in serum-free RPMI 1640 for 2 days, was rinsed with 
warm balanced salt solution (BSS) consisting of 130 mM NaC1, 
5 mM KCI, 1 mM MgCl2, 1.5 mM CaCl2 and 20 mM Hepes 
buffer at pH 7.4, and incubated for 15 min in warm BSS con- 
taining 10 mM glucose and 10 mM LiC1. The cells were in- 
cubated with the indicated oses of each LDL for 0-10 min at 
37°C. The reaction was terminated by placing the dishes on ice 
and changing the medium immediately to ice-cold 15% TCA. 
The culture dishes were kept on ice for 30 min and the cells were 
scraped. The extract was transferred to the test tube and TCA 
was removed by adding diethyl ether. This extract was 
neutralized by 0.1 N NaOH. IP3 was assayed using an IP3 assay 
kit (Amersbam). 
2.4. Agarose gel ectrophoresis 
Agarose gel electrophoresis was performed in barbital buffer 
at pH 8.6 in agarose gel as described by Noble [15], using an 
electrophoresis system (Ciba Corning). 
3. RESULTS 
Agarose  gel e lectrophores is  revealed that  
chemica l ly  mod i f ied  LDL  were negat ive ly  charged 
in var ious  degrees.  As hown in fig. 1, both  acetyl  
and ox id ized LDL  moved to the anode  side faster 
than  nat ive LDL .  The  degree o f  migrat ion  o f  
+ 
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Fig. 1. Electrophoretic 
B C 
mobility of native and chemically 
modified LDL preparations. 10/~g of protein of each LDL 
preparation was subjected to electrophoresis in agarose at pH 
8.6, after which the gel was tained with Fat Red 7B. The arrow 
indicates the origin. (A) Native LDL; (B) acetyl LDL; (C) 
oxidized LDL. 
chemica l ly  mod i f ied  LDL  var ied f rom each other:  
acetyl  LDL  migrated,  to some extent,  faster than 
ox id ized LDL .  
F ig .2  shows the t ime course study o f  IP3 fo rma-  
t ion in human monocyte -der ived  macrophages  
s t imulated by 30 /~g/ml  o f  nat ive and acetyl  LDL .  
Acety l  LDL  induced rapid IP3 fo rmat ion  in human 
monocyte -der ived  macrophages ,  and the max imal  
ef fect  was observed at 3 min.  Longer  incubat ion  
d imin ished IP3 fo rmat ion  probab ly  due to its 
faster degradat ion  than its fo rmat ion .  Nat ive  LDL  
o f  this dose showed on ly  sl ight IP3 fo rmat ion .  To  
conf i rm the max imal  ef fect  o f  acetyl  LDL  on IP3 
fo rmat ion  and to f ind out  whether  nat ive LDL  
st imulates IP3 fo rmat ion  at h igher  doses, we in- 
vest igated IP3 fo rmat ion  in human monocyte -  
der ived macrophages  t imulated by var ious  doses 
o f  nat ive and acetyl  LDL .  As shown in f ig.3, both  
nat ive and acetyl  LDL  s t imulated IP3 fo rmat ion  in 
a dose-dependent  manner  at concent ra t ions  o f  
0 -70 /~g/ml .  The amount  o f  IP3 in human 
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Fig.2. Time course study for IP~ formation in human 
monocyte-derived macrophages. 30/zg/ml of LDL was added 
to macrophage monolayers (20-40/~g cell protein/dish). The 
reaction was terminated by ice-cold 15070 TCA. IP3 was assayed 
as described in section 2. (e) Acetyl LDL; (©) native LDL. 
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Fig.3. IP3 formation in human monocyte-derived macrophages 
stimulated by various concentrations of acetyl and native LDL. 
Various concentrations of LDL were added to macrophage 
monolayers (20-40/~g cell protein/dish). After 3 min 
incubation, the reaction was terminated by ice-cold 15% TCA. 
IP3 was assayed as described in section 2. (o) Acetyl LDL; (o) 
native LDL. 
Table 1 
IP3 formation in macrophages stimulated by various LDL 
IPs formation 
nmol/mg protein % 
Acetyl LDL 0.44 100 
Oxidized LDL 0.41 93.1 
Native LDL 0.20 45.4 
None 0.079 17.9 
30/zg/ml of various LDL were added to each culture dish 
containing human monocyte-derived macrophages (20-40/~g 
cell protein/dish), incubated for 3 min. The reaction was 
terminated by ice-cold 15°70 TCA. IP3 was assayed as described 
in section 2 
monocyte-derived macrophages timulated by 
acetyl LDL was 2-fold greater than that by native 
LDL. 
Table 1 shows the potency of each LDL to pro- 
duce IP3 in human monocyte-derived macro- 
phages. IP3 formation was evaluated under the 
condition of 30/~g/ml of each LDL and 3 min of 
incubation. This condition was considered to pro- 
duce a nearly half-maximal effect on IP3 forma- 
tion. Acetyl, oxidized and native LDL induced 
0.44, 0.41 and 0.20 nmol/mg protein, respectively. 
Oxidized LDL stimulated IP3 formation with a 
similar efficiency to acetyl LDL (93.1% of that 
produced by acetyl LDL). 
4. DISCUSSION 
In this study, we showed that both native and 
acetyl LDL induced IP3 formation in human 
monocyte-derived macrophages. However, IP3 
formation stimulated by acetyl LDL was 2-fold 
greater than that by native LDL. The potency of 
LDL to stimulate IP3 formation seemed to be pro- 
portional to the degree of the negative charge of 
each LDL (fig.1 and table 1). Block et al. [16] 
described that native LDL, at concentrations high 
enough for receptor binding but not high enough 
to saturate the receptor, induced the activation of 
phosphatidylinositol turnover in human platelets, 
fibroblasts, lymphocytes, and rat smooth muscle 
cells. It is well known that phosphatidylinositol 
hydrolysis i  one of the important mechanisms of
intracellular signal transduction and cell activa- 
tion, which plays a crucial role in growth control 
37 
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and secretion [8,9]. IP~ formation in human 
monocyte-derived macrophages timulated by 
native and acetyl LDL indicates that these LDL ac- 
tivate macrophages. Beg et al. [17] reported that 
3-hydroxy-3-methylglutaryl-coenzyme A reductase 
(HMG-CoA reductase), a key enzyme in 
cholesterol synthesis, was regulated by protein 
kinase C in hepatocytes. Cyclic AMP was reported 
to induce a decrease in HMG-CoA reductase ac- 
tivity in the human hepatoma cell line HepG2 [18]. 
Cholesterol synthesis n macrophages is not so ac- 
tive as in hepatocytes, however, it is likely that the 
activation of macrophages by LDL results in the 
metabolic regulation or the release of biologically 
active substances toward cell proliferation. Indeed, 
activated macrophages have been reported to 
release macrophage-derived growth factor and 
stimulate non-lymphoid mesenchymal cell pro- 
liferation [19]. This study demonstrated that 
modified LDL, which are thought o form foam 
cells, induced IP3 formation 2-fold more than 
native LDL. This result may correspond to the 
phenomenon that macrophages are activated 
especially under pathological conditions. IP3 for- 
mation might play a crucial role in activating 
macrophages in the initial step of atherosclerosis. 
Future studies might investigate how macrophages 
respond to the stimulation by native and acetyl 
LDL after IP3 formation. 
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